Vaccinex, Inc. (VCNX) Total liabilities 2017–2024
Vaccinex, Inc. (VCNX) total liabilities at each fiscal year-end, per SEC filings.
$5.1MFY2024 · since FY2017: $7.3M → $5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $5.1M | -14.4% |
| FY2023 | $5.9M | +113.4% |
| FY2022 | $2.8M | +14.5% |
| FY2021 | $2.4M | -83.0% |
| FY2020 | $14.3M | +108.1% |
| FY2019 | $6.9M | +2.9% |
| FY2018 | $6.7M | -9.0% |
| FY2017 | $7.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice